Target intelligence / Profile preview

26S proteasome complex subunit DSS1 (DSS1)

Target
DSS1
Molecular classification
Proteasome subunit, Intrinsically disordered protein, Chaperone/assembly factor
01

Overview

26S proteasome complex subunit DSS1 (also known as SEM1) is an evolutionarily conserved, small, intrinsically disordered protein that functions as an integral component of the 19S regulatory particle "lid" of the 26S proteasome, the main ATP-dependent protease complex responsible for ubiquitin-mediated protein degradation in eukaryotes[1][2][4][5]. DSS1/SEM1 acts as a molecular tether, mediating the assembly and stability of the proteasome lid by specifically recruiting and stabilizing subunits such as Rpn3 and Rpn7 during proteasome maturation[2]. In addition to its role in proteasome assembly, DSS1/SEM1 participates in other multiprotein complexes, including the TREX-2 mRNA export complex and the BRCA2 complex involved in homologous recombination DNA repair[1][2][4]. Mutations or loss of DSS1/SEM1 can disrupt proteasome biogenesis, mitochondrial function, and lead to developmental defects such as split hand/foot malformation type 1, but it is not considered a direct therapeutic target or established biomarker in current clinical practice[1][2][4].

Other names
SEM1C7orf76SHFM1SHFDG1ECDPSMD15SHSF1SHFD1Split hand/foot deleted protein 1Deleted in split hand/split foot protein 1Split hand/foot malformation type 1 protein
02

Mechanism of action

Not drug-targeted; mechanism includes chaperone-like assembly function within the proteasome and facilitating the assembly or stability of multiprotein complexes[1][2][4].

03

Biological functions

Protein degradation (ubiquitin-proteasome pathway)Assembly of proteasome lidRNA export (TREX-2 complex)Homologous recombination (BRCA2 complex)Protein stability regulationMitochondrial integrity
04

Disease associations

Cancer (via interaction with BRCA2 and protein homeostasis)Split hand/foot malformation (developmental disorder)
05

Safety considerations

Not established as a drug target; loss or mutation associated with impaired proteasome assembly and developmental defects such as split hand/foot malformation[1]

Beyond the preview

Go deeper on 26S proteasome complex subunit DSS1 (DSS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 26S proteasome complex subunit DSS1 (DSS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call